Sun Pharmaceutical (SUNPHARMA) — concall transcript

📢 Key Event
Sun Pharma reported Q1 FY25 results with 40.2% YoY net profit growth driven by India volume expansion and specialty product performance.

🔄 What Changed
Net profit surged 40.2% YoY to ₹28,356 crores, while India formulation sales grew 16.4% YoY to capture 8.6% market share.

🔮 What's Next
Management expects R&D spend to step up in subsequent quarters and plans to out-license GLP-1 molecule pending clinical outcome clarity.

💡 Investor Takeaway
Strong profit growth and specialty momentum offset US softness, but regulatory risks and litigation over LEQSELVI require monitoring.

Sun Pharmaceutical reported consolidated sales of ₹125,245 crores up 6.3% YoY with net profit at ₹28,356 crores, up 40.2% YoY, driven by 16.4% growth in India formulation sales and strong specialty performance. Global specialty sales rose 14.7% to $266 million, while US business declined 1% due to seasonality. The company launched LEQSELVI for alopecia areata pending court resolution and plans to out-license its GLP-1 molecule. R&D investment was 6.3% of sales, with 45.2% allocated to specialty R&D. Cash balance stood at $2.3 billion as of June 2024.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Ltd (SUNPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,63,791.45 Cr P/E: 38.4 ROE: 14.6% ROCE: 18.7% Div Yield: 0.83%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How will LEQSELVI litigation impact US specialty revenue?" "What is the timeline for GLP-1 out-licensing decision?" "When will R&D spend increase and on which products?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 30 June 2024

BEL Bharat Electronics Ltd concall transcript INDIGO Interglobe Aviation Ltd concall transcript M&M Mahindra & Mahindra Ltd concall transcript ULTRACEMCO UltraTech Cement Ltd concall transcript TITAN Titan Company Ltd concall transcript SBIN State Bank of India concall transcript

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUNPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd